Kirkpatrick, PhD DL, Schmidt, PhD WK, Morales, BSc R, Cremin, PhD J, Seroogy, BSc J, Husfeld, PhD C, Jenkins, PhD T. In vitro and in vivo assessment of the abuse potential of PF614, a novel BIO-MD™ prodrug of oxycodone. J of Opioid Management [Internet]. 2017 Jan. 1 [cited 2024 Nov. 22];13(1):39-4. Available from: https://wmpllc.org/ojs/index.php/jom/article/view/555